CompletedPhase 4

Efficacy of Beraprost in Lowering Pulmonary Arterial Pressure in Children

Indonesia40 participantsStarted 2017-04-01

Plain-language summary

To analyze the efficacy of beraprost and sildenafil for treatment of pulmonary hypertension in children with left to right shunt. analyze the efficacy and side effects.

Who can participate

Age range1 Year – 17 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * diagnosed as pulmonary hypertension with left to right shunt CHD (VSD, ASD, PDA and combination) * agree to enroll in this study Exclusion Criteria: * suffer from chronic lung disease * suffer from soft tissue tumor, HIV/AIDS * under interferon therapy * already performed any cardiac surgery * already got anti-PH remedy

What they're measuring

Efficacy of Beraprost, Sildenafil and comparison between both drugs in lowering pulmonary arterial pressure

Timeframe: 12 weeks

Trial details

NCT IDNCT03431649

SponsorDr. Soetomo General Hospital

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2017-07-30

View on ClinicalTrials.gov More Pediatric Pulmonary Hypertension trials